SCHEMBL869883

SCHEMBL869883

NCC(=O)OC(=O)[C@@H](N)CCC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
KMT2A Q03164 1/20 0.50
DPP4 P27487 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
GRM8 O00222 1/20 0.33
GRM6 O15303 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GSR P00390 1/20 0.33
CYP1A2 P05177 1/20 0.33
GRIK1 P39086 1/20 0.33
GRM5 P41594 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA2 P42262 1/20 0.33
GRIA3 P42263 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5524401 0.98 ALOX15 (0.48) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL1685063 0.86 SLC1A1 (0.34) ALOX15BLMPMP22KMT2AGRM8
SCHEMBL352342 0.86 ALOX15 (0.52) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL28571398 0.86 ALOX15 (0.52) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL711607 0.86 ALOX15 (0.60) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL6673186 0.85 GRM8 (0.52) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL9452863 0.83 ALOX15 (0.48) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL7176759 0.82 ALOX15 (0.56) ALOX15BLMPMP22KMT2ADPP4
Potassium Ion SCHEMBL28353514 0.81 CA1 (0.36) ALOX15BLMPMP22KMT2AGRM8
SCHEMBL2443865 0.81 KMT2A (0.68) ALOX15BLMPMP22KMT2ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220354812-A1 COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR CANCER TREATMENT AND METABOLIC INTERVENTION THERAPY FILTRICINE, INC. 2022-11-10 US claimed
CN-115029304-A Human oocyte activator and application thereof 中国医科大学附属盛京医院 2022-09-09 CN claimed
US-11369127-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC NATURAL PRODUCTS CO., LTD. (CN) 2022-06-28 US claimed
US-11147295-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC NATURAL PRODUCTS, LTD. (CN) 2021-10-19 US claimed
US-20200352196-A1 SWEETENER AND FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF EPC NATURAL PRODUCTS CO., LTD. (CN) 2020-11-12 US claimed
US-20200337339-A1 SWEETENER AND FLAVOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF EPC NATURAL PRODUCTS CO., LTD. (CN) 2020-10-29 US claimed
EP-3107556-B1 COMPOSITIONS FOR PREVENTING AND/OR TREATING PATHOLOGICAL CONDITIONS ASSOCIATED WITH ALPHA-GLUCOSIDASE UNIV LA ROCHELLE (FR) 2019-04-10 EP claimed
CN-106456633-A Sugar metabolism improving agent 三得利控股株式会社 2017-02-22 CN claimed
CN-106455664-A Composition with high content of cyclic dipeptide 三得利控股株式会社 2017-02-22 CN claimed
WO-2015016826-A1 RUMINANT FEED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BENEMILK OY (FI) 2015-02-05 WO claimed
WO-2015016823-A1 DIETARY PASTE COMPOSITIONS FOR RUMINANTS AND METHODS OF MAKING AND USING THE SAME BENEMILK OY (FI) 2015-02-05 WO claimed
WO-2015016827-A1 DIETARY COMPOSITIONS FOR RUMINANTS AND CONTAINERS FOR STORING AND DISPENSING SAME BENEMILK OY (FI) 2015-02-05 WO claimed
EP-4734770-A1 COMPOUNDS THAT MODULATE GPRC6A RECEPTOR AND PET FOOD PRODUCTS CONTAINING THE SAME Mars, Incorporated (US) 2026-05-06 EP disclosed
WO-2025006362-A1 COMPOUNDS THAT MODULATE GPRC6A RECEPTOR AND PET FOOD PRODUCTS CONTAINING THE SAME MARS, INCORPORATED (US) 2025-01-02 WO disclosed
US-12029228-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC Natural Products Co., Ltd (CN) 2024-07-09 US disclosed
US-11985994-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC Natural Products Co., Ltd (CN) 2024-05-21 US disclosed
WO-1997026912-A9 ANTI-CD18 ANTIBODIES FOR USE AGAINST STROKE 1997-11-13 WO disclosed
US-5428007-A Increasing oxygenation in hypoxic cells of normal and tumor tissue YALE UNIVERSITY (US) 1995-06-27 US disclosed
US-5173426-A Pure polynucleotide; for increasing tissue oxygenation in patients YALE UNIVERSITY (US) 1992-12-22 US disclosed
US-5162373-A Gut Atrophy Prevention, Ornithine, Methionine BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-11-10 US disclosed